SecBot SecBot
8-K ·Filed Sep 9, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001645113-26-000068
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine board retirement with no financial or operational implications. No trading action warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$15.63
T+0 close · Sep 9, 2026 · via day close
Latest settled
−6.21%
T+20 · $14.66 · next T+60 in 16d
Vs SPY
−8.40%
α at T+20
Latest observation
−14.69%
T+46 · FF3 residual α
  1. T+0 · Sep 9 $15.63entry
  2. T+1 · 2mo ago −1.79%α −1.19% · $15.35
  3. T+5 · 2mo ago +4.80%α +5.13% · $16.38
  4. T+20 · 6w ago −6.21%α −8.40% · $14.66
  5. T+48 · todayOpen
  6. T+60 · in 16d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Timothy Scannell retired from NovoCure's board effective September 2, 2026, after five years of service. The filing explicitly states his departure did not result from any disagreement with the company or management. This is a routine board transition with no material financial impact.

Key Facts

  • Director Timothy Scannell retired from the board effective September 2, 2026.
  • Scannell served for five years.
  • The retirement did not result from any disagreement with the company or its management.
  • No replacement was named in the filing.

Financial Impact

No financial impact disclosed.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001645113-26-000068
Document: 0001645113-26-000068-index-headers.html0001645113-26-000068
Document: 0001645113-26-000068-index.html0001645113-26-000068
Document: 0001645113-26-000068.txt0001645113-26-000068

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Viewing Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026